Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Veronika Mancikova"'
Autor:
Veronika Mancikova, Michaela Pesova, Sarka Pavlova, Robert Helma, Kristyna Zavacka, Vaclav Hejret, Petr Taus, Jakub Hynst, Karla Plevova, Jitka Malcikova, Sarka Pospisilova
Publikováno v:
Molecular Oncology, Vol 17, Iss 1, Pp 82-97 (2023)
TP53 gene abnormalities represent the most important biomarker in chronic lymphocytic leukemia (CLL). Altered protein modifications could also influence p53 function, even in the wild‐type protein. We assessed the impact of p53 protein phosphorylat
Externí odkaz:
https://doaj.org/article/d23f7fd800de4b44a79aa2866eceb35e
Autor:
Cristina Montero‐Conde, Luis Javier Leandro‐García, Ángel M. Martínez‐Montes, Paula Martínez, Francisco J. Moya, Rocío Letón, Eduardo Gil, Natalia Martínez‐Puente, Sonsoles Guadalix, Maria Currás‐Freixes, Laura García‐Tobar, Carles Zafon, Mireia Jordà, Garcilaso Riesco‐Eizaguirre, Patricia González‐García, María Monteagudo, Rafael Torres‐Pérez, Veronika Mancikova, Sergio Ruiz‐Llorente, Manuel Pérez‐Martínez, Guillermo Pita, Juan Carlos Galofré, Anna Gonzalez‐Neira, Alberto Cascón, Cristina Rodríguez‐Antona, Diego Megías, María A. Blasco, Eduardo Caleiras, Sandra Rodríguez‐Perales, Mercedes Robledo
Publikováno v:
Clinical and Translational Medicine, Vol 12, Iss 8, Pp n/a-n/a (2022)
Background Comprehensive molecular studies on tumours are needed to delineate immortalization process steps and identify sensitive prognostic biomarkers in thyroid cancer. Methods and Results In this study, we extensively characterize telomere‐rela
Externí odkaz:
https://doaj.org/article/50de3fcc7b624a41bff4004a50893619
Autor:
Veronika Mancikova, Helena Peschelova, Veronika Kozlova, Aneta Ledererova, Adriana Ladungova, Jan Verner, Tomas Loja, Sarka Pospisilova, Michal Smida, Lenka Dostalova, Martin Culen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021)
Background Anti-CD19 chimeric antigen receptor T cells (CART-19) frequently induce remissions in hemato-oncological patients with recurred and/or refractory B-cell tumors. However, malignant cells sometimes escape the immunotherapeutic targeting by C
Externí odkaz:
https://doaj.org/article/6bcdb3d13e154c7d93d622142968214e
Autor:
Veronika Mancikova, Helena Peschelova, Veronika Kozlova, Aneta Ledererova, Adriana Ladungova, Jan Verner, Tomas Loja, Frantisek Folber, Jiri Mayer, Sarka Pospisilova, Michal Smida
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background While achieving prolonged remissions in other B cell-derived malignancies, chimeric antigen receptor (CAR) T cells still underperform when injected into patients with chronic lymphocytic leukemia (CLL). We studied the influence of genetics
Externí odkaz:
https://doaj.org/article/259c3cf68f02459a9b6f9eafc6fa6aa2
Autor:
Iñigo Landa, Cesar Boullosa, Lucía Inglada-Pérez, Ana Sastre-Perona, Susana Pastor, Antonia Velázquez, Veronika Mancikova, Sergio Ruiz-Llorente, Francesca Schiavi, Ricard Marcos, Nuria Malats, Giuseppe Opocher, Ramon Diaz-Uriarte, Pilar Santisteban, Alfonso Valencia, Mercedes Robledo
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e74765 (2013)
Papillary Thyroid Cancer (PTC) is a heterogeneous and complex disease; susceptibility to PTC is influenced by the joint effects of multiple common, low-penetrance genes, although relatively few have been identified to date. Here we applied a rigorous
Externí odkaz:
https://doaj.org/article/4c1f6195c3314c3c9d7f014736d1cc8e
Autor:
Iñigo Landa, Cesar Boullosa, Lucía Inglada-Pérez, Ana Sastre-Perona, Susana Pastor, Antonia Velázquez, Veronika Mancikova, Sergio Ruiz-Llorente, Francesca Schiavi, Ricard Marcos, Nuria Malats, Giuseppe Opocher, Ramon Diaz-Uriarte, Pilar Santisteban, Alfonso Valencia, Mercedes Robledo
Publikováno v:
PLoS ONE, Vol 8, Iss 10 (2013)
Externí odkaz:
https://doaj.org/article/a6a04b4068b148fa95548eb42e330427
Autor:
Veronika Mancikova, Michaela Pesova, Sarka Pavlova, Robert Helma, Kristyna Zavacka, Vaclav Hejret, Petr Taus, Jakub Hynst, Karla Plevova, Jitka Malcikova, Sarka Pospisilova
Publikováno v:
MOLECULAR ONCOLOGY
TP53 gene abnormalities represent the most important biomarker in chronic lymphocytic leukemia (CLL). Altered protein modifications could also influence p53 function, even in the wild-type protein. We assessed the impact of p53 protein phosphorylatio
Autor:
Mercedes Robledo, Mario Fraga, Xavier Matias-Guiu, Mario Encinas, Salud Borrego, Esmeralda Castelblanco, Lucia Inglada-Pérez, Karolina Jodkowska, María Santacana, Agustin Fernandez, Javier Perales-Paton, Cristina Montero-Conde, Veronika Mancikova
Primers used in the mutation analysis of the samples. Examples of identified mutations are also shown.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5936b6a024315bfea68ffc6871781479
https://doi.org/10.1158/1078-0432.22467042
https://doi.org/10.1158/1078-0432.22467042
Autor:
Cristina Rodríguez-Antona, Mercedes Robledo, Alberto Cascón, Veronika Mancikova, Iñaki Comino-Méndez, Aguirre A. de Cubas, Agnieszka Maliszewska, Lucia Inglada-Perez, M. Eileen Dolan, Heather E. Wheeler, Elisabeth Åvall-Lundqvist, Henrik Gréen, Carlos Jara, Susanna Leskelä, Luis J. Leandro-García
PDF file, 101KB, TUBB2A promoter variants in individuals high and low β-tubulin IIa mRNA expression.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47260af210bb52463741e1542e10f13f
https://doi.org/10.1158/1078-0432.22446396
https://doi.org/10.1158/1078-0432.22446396
Autor:
Cristina Rodríguez-Antona, Mercedes Robledo, Alberto Cascón, Veronika Mancikova, Iñaki Comino-Méndez, Aguirre A. de Cubas, Agnieszka Maliszewska, Lucia Inglada-Perez, M. Eileen Dolan, Heather E. Wheeler, Elisabeth Åvall-Lundqvist, Henrik Gréen, Carlos Jara, Susanna Leskelä, Luis J. Leandro-García
PDF file, 95KB.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fa4d8c85c445afc62014b8e83ed15ea
https://doi.org/10.1158/1078-0432.22446402.v1
https://doi.org/10.1158/1078-0432.22446402.v1